Ozempic (semaglutide), a glucagon-like peptide-1 (GLP-1) receptor agonist, is commonly prescribed for type 2 diabetes management, whilst blood thinners prevent dangerous blood clots
More recent results from the STEP UP trial show that higher doses can lead to an average weight loss of about 21%, with some individuals losing 25% or more of their starting weight, offering even greater potential for improved health and confidence
brand-name options At TOM Weight Loss, our memberships include compounded semaglutide or tirzepatide with the medication included, and we also offer an la carte plan for brand-name GLP-1s such as Wegovy, Ozempic, Zepbound, and Mounjaro
Endometriosis-exposed peritoneal fluid has high numbers of peritoneal macrophages associated with an increased inflammatory response and activation of the NFB pathway